|
|
Volumn 30, Issue 8, 2002, Pages 547-548
|
|
ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia (multiple letters)
a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACUTE DISEASE;
ALLOTRANSPLANTATION;
BLOOD GROUP ABO SYSTEM;
BLOOD GROUP INCOMPATIBILITY;
BONE MARROW TRANSPLANTATION;
HUMAN;
IMMUNOLOGY;
MYELOID LEUKEMIA;
NOTE;
RECURRENT DISEASE;
ACUTE GRANULOCYTIC LEUKEMIA;
ALLOGENIC BONE MARROW TRANSPLANTATION;
BLOOD GROUP ABO INCOMPATIBILITY;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL OBSERVATION;
CONTROLLED STUDY;
DONOR;
GRAFT VERSUS HOST REACTION;
HEMATOLOGIC MALIGNANCY;
HISTOCOMPATIBILITY;
HLA MATCHING;
IMMUNE RESPONSE;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
PROBABILITY;
PROGNOSIS;
PROPHYLAXIS;
RECURRENCE RISK;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
SAMPLE SIZE;
TREATMENT OUTCOME;
WHOLE BODY RADIATION;
ABO BLOOD-GROUP SYSTEM;
ACUTE DISEASE;
BLOOD GROUP INCOMPATIBILITY;
BONE MARROW TRANSPLANTATION;
HUMANS;
LEUKEMIA, MYELOID;
RECURRENCE;
TRANSPLANTATION, HOMOLOGOUS;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
HEMAGGLUTININ;
HLA ANTIGEN;
MELPHALAN;
METHOTREXATE;
|
|
EID: 0036810188
PISSN: 02683369
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bmt.1703706 Document Type: Letter |
|
Times cited : (10)
|
|
References (0)
|